Why do some people with COVID-19 experience little more than a sniffle while others end up on a ventilator? And among critically ill patients, why do some eventually recover while others do not?
A new study has unveiled clues for helping scientists predict who is most at risk for severe COVID-19, and among those who experience severe disease, who is most likely to survive. The study drew on data from the Immunophenotyping Assessment in a COVID-19 Cohort (IMPACC) study, a partnership between the National Institute of Allergy and Infectious Diseases (NIAID) and 15 research institutions across the country, including Yale School of Medicine (YSM)…
Read the full article here.